All the aluminum hydroxide (alum)-immunized GPs succumbed to anthrax 3–4 days postinfection, while r0190 or rPA protected 50% of the challenged GPs and 83% of those immunized with r0190 plus rPA were protected against B. anthracis spore challenge (Fig. 5a). Here, RPA1 is linked to anthrax infection.